Tonix Pharmaceuticals Enters Into Research Collaboration And Exclusive License Agreement With University Of Alberta To Develop Novel Horsepox-Based Vaccines, TNX-1810, TNX-1820 And TNX-1830, For Prevention Of Coronavirus COVID-19